Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 36 results for "merck co"

Merck cholesterol drug Vytorin faces competition from Impax, Teva generics

FDA clears Merck's Keytruda based on cancer genetics, not loca...

Merck & Co's immunotherapy Keytruda on Tuesday became the first cancer drug ever approved by the U.S. Food and Drug Administration based on a patients' specific genetic traits, regardless of where in the body the disease originated. The approval marks a major ... Reuters, 5 days ago

147 images for merck co

WKRB News, 4 months ago
American Banking News, 4 months ago
SleekMoney, 4 months ago, 3 months ago
Yahoo! News, 4 months ago, 4 months ago
SRN News, 3 months ago
4 Traders, 4 months ago
Ticker Report, 5 months ago
American Banking News, 4 months ago

Germany's Merck plans divestment of biosimilars business

Merck has a strategic alliance with India's Dr Reddy's Labs to co-develop multiple cancer drugs BS B2B Bureau | Darmstadt, Germany March 14, 2017 Last Updated at 12:37 IST Merck KGaA, the German firm that specialises in chemical, pharmaceutical and life ...
 Business Standard2 months ago
Money Control

Glenmark partners Evestra to market contraceptive product in US

They have signed pact for a generic version of Merck & Co's NuvaRing, a contraceptive vaginal ring Rakesh Rao | Mumbai March 2, 2017 Last Updated at 10:45 IST Glenmark Pharmaceuticals and the US-based Evestra Inc have completed a strategic development, ...
 Business Standard2 months ago Glenmark, Evestra enter pact for generic contraceptive product  Business Standard2 months ago Glenmark Pharma and Evestra announce partnership agreement for generic NuvaRing  Money Control2 months ago

UK competition watchdog accuses Merck of obstructing biosimilars

LONDON (Reuters) - Britain's competition watchdog has accused Merck & Co of operating an unfair discount scheme for its medicine Remicade that it said was designed to restrict competition from so-called biosimilar copies.
 Reuters5 days ago UK rejects Merck's Keytruda as initial treatment for lung cancer  Reuters2 months ago

Merck, Upsher-Smith to pay $60 million in 'pay-for-delay' drug case

Merck & Co Inc and Upsher-Smith Laboratories Inc have agreed to pay $60.2 million to resolve a lawsuit that said they entered into a deal to unlawfully delay the availability of generic versions of potassium supplement K-Dur. The settlement, disclosed in ...
 Reuters1 week ago

Merck must face renewed Fosamax warning claims: U.S. appeals court

A federal appeals court on Wednesday revived claims by several hundred plaintiffs who accused Merck & Co of failing to adequately warn about the risks of thigh bone fractures associated with its osteoporosis drug Fosamax. In a 3-0 decision, the 3rd U.S.
 Reuters2 months ago

Sensex Opens Higher; Lupin Plunges 5.5% on Weak Q4 Numbers

Posted by Equitymaster Stock markets in Asia are higher today as investors look ahead to an OPEC gathering widely expected to extend output cuts. The Nikkei 225 is up 1.20%, while the Hang Seng is up 0.54%. The Shanghai Composite is trading higher by 0.09%.
 Equitymaster.com4 days ago

Wall Street slides as investors fret about retail

By Noel Randewich (Reuters) - U.S. stocks fell on Thursday after worse-than-expected sales drops at Macy's and Kohl's sparked a selloff in shares of department stores and stirred fears that consumers are not spending enough to drive strong economic growth.
 Sify2 weeks ago US STOCKS-Wall Street drops as investors worry about retail  Sify2 weeks ago US STOCKS-Wall Street slides as investors fret about retail  Sify2 weeks ago Wall Street drops as investors worry about retail  Sify2 weeks ago

As AstraZeneca chases rivals, immuno-oncology gets complicated| Reuters

By Ben Hirschler | LONDON LONDON Three years after Pfizer's failed bid for AstraZeneca, the British drugmaker aims to prove in the coming weeks that its cancer immunotherapy can deliver on bold sales forecasts made during that takeover battle.Central to ...
 First Post.com1 month ago

Low-cost male contraceptive finds no takers

It could ease the burden on the 225 million women in developing countries, says Ari Altstedter. IMAGE: Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval. Photograph: Robert Cianflone/Getty Images Doctors are on the cusp of launching a male contraceptive. But rather than a big pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India. Years of human ...
 Rediff.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less